Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT00843193
Eligibility Criteria:
Inclusion Criteria:
* history of asthma for ≥ 6 months
* taking inhaled corticosteroids
* non-smoking
* Baseline (pre-bronchodilator) FEV1 35-80% predicted at screening.
* Reversible airways disease as indicated by an increase of FEV1 ≥12% from baseline after nebulised salbutamol or albuterol.
* symptomatic according to the ACQ-7
Exclusion Criteria:
* Unstable severe asthma
* Recent respiratory illness
* Presence of other respiratory disease or chronic pulmonary condition other than asthma
* Treatment with omalizumab within 4 months of study
* Recent gastrointestinal or respiratory parasitic infestation
* History of severe allergy to food or drugs
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00843193
Study Brief:
Protocol Section:
NCT00843193